4//SEC Filing
Martin James Joseph 4
Accession 0001493152-24-040900
CIK 0001412486other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 4:05 PM ET
Size
5.7 KB
Accession
0001493152-24-040900
Insider Transaction Report
Form 4
Martin James Joseph
Co-CEO and CFO
Transactions
- Award
Common Stock
2024-10-09+40,000→ 40,569 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by the Board of Directors of the Issuer. One half of the RSUs are fully vested, with the balance vesting in eight equal quarterly installments on the last day of each quarter commencing with the quarter ending September 30, 2025, subject to continued services for the Company as of each applicable vesting date. Shares of common stock will be delivered to the Reporting Person promptly upon vesting, unless the Reporting Person elects to defer delivery. The RSUs were granted under the Issuer's 2015 Equity Incentive Plan and will vest in full upon a Change of Control as defined in such Plan.
Documents
Issuer
Cocrystal Pharma, Inc.
CIK 0001412486
Entity typeother
Related Parties
1- filerCIK 0001510224
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 4:05 PM ET
- Size
- 5.7 KB